ArticleClinical neuroradiology2025
Clinical Outcomes and Predictors of Precise Stent Placement in Patients with Isolated Pulsatile Tinnitus.
Article in Clinical neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Temporal bone remodeling after venous stenting for pulsatile tinnitus: isolated dehiscence versus diverticulum.European radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeThere is no dedicated stent for isolated venous pulsatile tinnitus (IVPT). This retrospective study aimed to evaluate the the clinical outcomes and associated factors of Precise stent (Cordis) implantation in the management of IVPT.
methodsWe analyzed data from IVPT patients treated at our center between December 2009 and August 2024. Baseline characteristics, venous sinus morphology, endovascular techniques, clinical outcomes, and follow-up data were reviewed.
resultsAmong 111 IVPT patients, 64 (57.7%) underwent cranial venous sinus stenting (CVSS) using the Precise stent, with 59 (92.2%) being women. IVPT resolved immediately after CVSS in all cases. Over a mean follow-up of 90.9 ± 42.7 months, 18 patients (28.1%) experienced postoperative headaches, all female, with 61.1% reporting symptoms within the first week. Headaches had a mean duration of 44.9 ± 70.5 days and an average visual analog scale score of 3.4 ± 1.5, with 94.5% described as pressure-like. Younger age was significantly associated with headache occurrence (P < 0.05), while other factors, including stent size and operation time, showed no correlation.
conclusionPrecise stent implantation in venous sinus is highly effective for treating IVPT, but postoperative headaches, particularly in younger women, are a common complication. Further research is needed to mitigate these side effects and enhance long-term patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.